
David Cook has been appointed chief financial officer (CFO) of drug development firm Biotie Therapies and will become a member …
AbbVie, the new $18 billion biopharma company which includes many of Abbott’s most high profile products, has finally launched. Abbott …
The world’s largest pharma companies will be under greater pressure to merge with or purchase other firms over the next …

A new lower price and new data analysis has persuaded NICE to recommend Lucentis for patients with diabetic macular oedema …

Celgene has announced the appointment of Sarah Bater as director of Human Resources, Celgene UK and Ireland. Bater brings a wealth …
Synteract agrees to by Harrison Clinical Research, WuXi forges JV with PR, plus appointments and a new accreditation for Quintiles’ …
BASF extends offer for ProNova, Patheon closes Banner Pharmacaps deal, plus updates from Amarin, Biogen Idec/Eisai and Lonza.
The Department of Health has signalled its desire to make a splash in the digital pond with the release of …

Glass and plastic packaging specialist Gerresheimer has acquired a majority stake in Indian company Triveni Polymers Pvt in a bid …
Merck KGaA’s pipeline has been dented by the ‘disappointing’ late-stage failure of Stimuvax in a programme with non-small cell lung …

The NHS Commissioning Board’s blueprint for care has promised extra funds for health providers and greater transparency for patients. Board …

Sanofi has announced that Hanspeter Spek, president, Global Operations, will retire from his current role in mid-2013. Christopher Viehbacher, chief executive …

The NHS’s possible move to seven-day working has received a mixed welcome, with the BMA dubbing the proposals ‘too crude’. …

Amgen has pleaded guilty to misbranding its anaemia drug Aranesp following a string of US lawsuits against the biotech company. The …
NICE has published its first guidance on good practice for those involved in working out what medicines should be made …
Sanofi is no different from any other major pharma company in seeing China as the single most important growth market …
The government looks to be heading towards a showdown with clinician groups over proposed changes to doctors’ contracts. It has …

Fine chemicals company Evonik Degussa has announced job cuts as part of an efficiency drive at a US plant making …

David Haslam has been confirmed as chair of the National Institute for Health and Clinical Excellence. Professor Haslam is currently …

Generic pharma company Hospira’s efforts to bring its manufacturing network back into compliance took a knock this week when it …